SCHEMBL4189871

SCHEMBL4189871

O=C(C(=O)c1ccc(Oc2ccccc2)cc1)c1ccc(Oc2ccccc2)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP10 Q53GL7 2/20 0.69
SRD5A2 P31213 4/20 0.67
CES2 O00748 4/20 0.64
CES1 P23141 4/20 0.64
ERCC5 P28715 1/20 0.58
FEN1 P39748 1/20 0.58
LTA4H P09960 2/20 0.57
TSHR P16473 1/20 0.57
NR1H2 P55055 1/20 0.56
BAX Q07812 1/20 0.56
AKR1C3 P42330 1/20 0.55
PGR P06401 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
ALDH1A1 P00352 1/20 0.54
KMT2A Q03164 1/20 0.54
PARP15 Q460N3 1/20 0.54
PARP14 Q460N5 1/20 0.54
PARP16 Q8N5Y8 1/20 0.54
PARP11 Q9NR21 1/20 0.54
PARP4 Q9UKK3 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9242631 0.98 CES2 (0.68) PARP10SRD5A2CES2CES1ERCC5
SCHEMBL13567254 0.95 CES2 (0.71) PARP10SRD5A2CES2CES1ERCC5
SCHEMBL2134251 0.95 CES2 (0.71) PARP10SRD5A2CES2CES1ERCC5
SCHEMBL9250736 0.95 CES2 (0.71) PARP10SRD5A2CES2CES1ERCC5
SCHEMBL9807208 0.91 PARP10 (0.64) PARP10SRD5A2CES2CES1ERCC5
SCHEMBL4166171 0.91 PARP10 (0.64) PARP10SRD5A2CES2CES1ERCC5
SCHEMBL11034320 0.90 AKR1C3 (0.61) PARP10SRD5A2CES2CES1ERCC5
SCHEMBL13569201 0.89 CES2 (0.57) PARP10SRD5A2CES2CES1ERCC5
SCHEMBL14614403 0.89 CES2 (0.57) PARP10SRD5A2CES2CES1ERCC5
SCHEMBL13569209 0.89 CES2 (0.57) PARP10SRD5A2CES2CES1ERCC5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1476416-B1 MULTIFUNCTIONAL MONOMERS AND THEIR USE IN MAKING CROSS-LINKED POLYMERS AND POROUS FILMS DOW GLOBAL TECHNOLOGIES LLC (US) 2015-12-30 EP disclosed
EP-1476416-B1 MULTIFUNCTIONAL MONOMERS AND THEIR USE IN MAKING CROSS-LINKED POLYMERS AND POROUS FILMS DOW GLOBAL TECHNOLOGIES LLC (US) 2015-12-30 EP disclosed
US-7635741-B2 Curable polyacetylenes used as dielectrics in making microelectronics such as integrated circuits DOW GLOBAL TECHNOLOGIES INC. 2009-12-22 US disclosed
US-7635741-B2 Curable polyacetylenes used as dielectrics in making microelectronics such as integrated circuits DOW GLOBAL TECHNOLOGIES INC. 2009-12-22 US disclosed
US-7635741-B2 Curable polyacetylenes used as dielectrics in making microelectronics such as integrated circuits DOW GLOBAL TECHNOLOGIES INC. 2009-12-22 US disclosed
US-7585928-B2 monomers of acetylenic homo- or copolymers; cured polymers has low dielectric constant as insulating layers in microelectronic devices DOW GLOBAL TECHNOLOGIES (US) 2009-09-08 US disclosed
US-7585928-B2 monomers of acetylenic homo- or copolymers; cured polymers has low dielectric constant as insulating layers in microelectronic devices DOW GLOBAL TECHNOLOGIES (US) 2009-09-08 US disclosed
US-20070027278-A1 Multifunctional monomers containing bound mesogenic poragen forming moieties and polyarylene compositions therefrom DOW GLOBAL TECHNOLOGIES LLC 2007-02-01 US disclosed
US-20070027278-A1 Multifunctional monomers containing bound mesogenic poragen forming moieties and polyarylene compositions therefrom DOW GLOBAL TECHNOLOGIES LLC 2007-02-01 US disclosed
US-6979737-B1 Quinoxaline-containing AB2 monomer for hyperbranched aromatic poly(ether-ketones) THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) 2005-12-27 US disclosed
EP-0401296-B1 RIGID-ROD POLYMERS MAXDEM INC (US) 1998-04-01 EP disclosed
US-5659005-A Rigid-rod polymers MAXDEM INCORPORATED (US) 1997-08-19 US disclosed
US-5565543-A Rigid-rod polymers MAXDEM INCORPORATED (US) 1996-10-15 US disclosed
US-5227457-A Rigid-rod polymers MAXDEM INCORPORATED (US) 1993-07-13 US disclosed
EP-0489085-A4 RIGID-ROD POLYMERS MAXDEM INC (US) 1992-08-05 EP disclosed
EP-0489085-A1 RIGID-ROD POLYMERS MAXDEM INCORPORATED (US) 1992-06-10 EP disclosed
EP-0401296-A4 RIGID-ROD POLYMERS MAXDEM INC (US) 1992-03-18 EP disclosed
WO-1991002764-A1 RIGID-ROD POLYMERS MAXDEM INCORPORATED (US) 1991-03-07 WO disclosed
EP-0401296-A1 RIGID-ROD POLYMERS MAXDEM INCORPORATED (US) 1990-12-12 EP disclosed
WO-1989007617-A1 RIGID-ROD POLYMERS MAXDEM INCORPORATED (US) 1989-08-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070027278-A1 Multifunctional monomers containing bound mesogenic poragen forming moieties and polyarylene compositions therefrom LRBA, CD74, BMP2 PARP10 330/4885SRD5A2 1699/4885CES2 1665/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.